000			02083 a2200529 4500
005			20250516213124.0
264		0	_c20150223
008			201502s 0 0 eng d
022			_a2213-2619
024	7		_a10.1016/S2213-2600(14)70065-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aDecramer, Marc
245	0	0	_aEfficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. _h[electronic resource]
260			_bThe Lancet. Respiratory medicine _cJun 2014
300			_a472-86 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Inhalation
650	0	4	_aAged
650	0	4	_aBenzyl Alcohols _xadministration & dosage
650	0	4	_aBronchodilator Agents _xadministration & dosage
650	0	4	_aChlorobenzenes _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aForced Expiratory Volume _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdrug therapy
650	0	4	_aQuinuclidines _xadministration & dosage
650	0	4	_aScopolamine Derivatives _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTiotropium Bromide
650	0	4	_aTreatment Outcome
700	1		_aAnzueto, Antonio
700	1		_aKerwin, Edward
700	1		_aKaelin, Thomas
700	1		_aRichard, Nathalie
700	1		_aCrater, Glenn
700	1		_aTabberer, Maggie
700	1		_aHarris, Stephanie
700	1		_aChurch, Alison
773	0		_tThe Lancet. Respiratory medicine _gvol. 2 _gno. 6 _gp. 472-86
856	4	0	_uhttps://doi.org/10.1016/S2213-2600(14)70065-7 _zAvailable from publisher's website
999			_c23832719 _d23832719